Answers are grounded in this paper and cite their sources.
Artemisia cina Berg ex Poljakov, a shrubby plant endemic to the semi-arid areas of Kazakhstan, has as a long history of being used in traditional medicines as an antitumour, antifungal and anthelmintic agent. In a preliminary study carried out on different methodologies to produce aqueous extracts of A. cina it was seen that a simple aqueous extract of A. cina (as in an infusion of the plant) had the strongest anti-SARS-CoV-2 activity. The profiling of this aqueous extract was performed using Liquid Chromatography-Electrospray Ionization-Quadrupole-Time-of-Flight Mass Spectrometry (LC-ESI-Q-TOF-MS) while High-Speed Countercurrent Chromatography (HSCCC) and a Sephadex LH-20 column were utilised to isolate and purify the extract in ethyl acetate obtained from the aqueous extract. Nuclear Magnetic Resonance (NMR) was used for structural elucidation. The flavonoid spinacetin-7-O-glucoside was found to be one of the main compounds present in the A. cina aqueous extract. With the emergence of the COVID-19 pandemic and the frequency in which new COVID strains occur, the demand for drugs with anti-SARS-CoV-2 activity is at an all-time high. Flavonoids and artemisinin identified by LC-MS in this extract are hypothesised to be the key compounds behind the anti-SARS-CoV-2 activity of the aqueous extract, however this needs to be further tested and explored.
No takes yet. Share an insight, caveat, or question.
Tshunungwa et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: